Product Name: Bremelanotide
CAS No: 189691-06-3
Purity: 95%
Molar Mass: 1025.16
Chemical Formula: C50H68N14O10
Synonyms: PT 141, Vyleesi
Storage: Store at -20℃
Sequence: XDHFRWK
Target: Melanocortin (MC) Receptors
Application: Bremelanotide (CAS: 189691-06-3) is a peptide drug that functions as a melanocortin receptor agonist, specifically targeting the melanocortin-4 receptor (MC4R). It exerts its effects by activating MC4R, which regulates appetite and sexual arousal. Bremelanotide has gained attention for its use in the treatment of female sexual dysfunction, including hypoactive sexual desire disorder (HSDD). By stimulating sexual arousal pathways in the brain, bremelanotide has shown promise in enhancing libido and sexual satisfaction in women. In the field of pharmaceutical chemistry, bremelanotide’s mechanism of action on the central nervous system makes it an intriguing candidate for further research into therapies for sexual disorders and related conditions. Its potential applications extend to organic chemistry, where its peptide structure may serve as a template for the development of novel drug candidates targeting MC4R and other melanocortin receptors. Furthermore, bremelanotide’s role in sexual health underscores its significance in improving quality of life and addressing unmet medical needs in this domain.
Reference: Dhillon, S., & Keam, S. J. (2019). Bremelanotide: first approval. Drugs, 79(14), 1599-1606.
